Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)

28.55 +0.44 (+1.57%) 收市：05:00PM NZST

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

版塊: Healthcare
行業: Medical Instruments & Supplies
全職員工: 6,391

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Lewis G. Gradon	MD, CEO & Executive Director	2.56M	無	1961
Ms. Lyndal York	Chief Financial Officer	無	無	無
Andy Niccol	COO & GM of Respiratory Humidification	無	無	無
Dr. Andrew Somervell	Vice President of Products & Technology	無	無	無
Hayden Brown	Head of Capital Markets & Investor Relations	無	無	無
Raelene Leonard	Company Secretary & General Counsel	無	無	無
Daniel Adolph	Senior Communications & Investor Relations Manager	無	無	無
Mr. Justin Callahan	VP of Sales & Marketing and President of North America & Europe	無	無	無
Ms. Nicola Talbot	Vice President of Human Resources	無	無	無
Mr. Jonathan Rhodes	Vice President of Supply Chain, Facilities & Sustainability	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 NZD。

描述

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

公司管治

截至 2024年5月1日 止，Fisher & Paykel Healthcare Corporation Limited 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中：5；董事會：5；股東權利：7；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。